{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:41:01Z","timestamp":1789195261399,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR150-25"],"award-info":[{"award-number":["W.OR150-25"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.TR19-01"],"award-info":[{"award-number":["W.TR19-01"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.TR23-02"],"award-info":[{"award-number":["W.TR23-02"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.nmd.2024.08.005","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T11:48:11Z","timestamp":1723895291000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comprehensive four-year disease progression assessment of myotonic dystrophy type 1"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2004-1314","authenticated-orcid":false,"given":"Leandre A","family":"la Fontaine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E","family":"Bruijnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran HP","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Gorissen-Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse EA","family":"Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde MH","family":"Braakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Klinkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Mul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Bram AC","family":"\u2018t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander MJ","family":"van Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel GM","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar SJ","family":"Merkies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.nmd.2024.08.005_bib0001","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1212\/WNL.0000000000011425","article-title":"Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program","volume":"96","author":"Johnson","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2024.08.005_bib0002","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2019 end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook","year":"1992","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.nmd.2024.08.005_bib0003","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","article-title":"Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification","volume":"172","author":"De Antonio","year":"2016","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nmd.2024.08.005_bib0004","series-title":"Myotonic dystrophy","author":"Harper","year":"2009"},{"issue":"4","key":"10.1016\/j.nmd.2024.08.005_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MD.0b013e318226046b","article-title":"Organ dysfunction and muscular disability in myotonic dystrophy type 1","volume":"90","author":"Kaminsky","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.nmd.2024.08.005_bib0006","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00415-020-09970-6","article-title":"Change over time in ability to perform activities of daily living in myotonic dystrophy type 1","volume":"267","author":"Landfeldt","year":"2020","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.nmd.2024.08.005_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11940-018-0513-6","article-title":"Current and emerging therapies for Duchenne muscular dystrophy","volume":"20","author":"Crone","year":"2018","journal-title":"Current treatment options in neurology"},{"issue":"4","key":"10.1016\/j.nmd.2024.08.005_bib0008","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrneurol.2018.4","article-title":"Advances in therapy for spinal muscular atrophy: promises and challenges","volume":"14","author":"Groen","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2024.08.005_bib0009","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.drudis.2021.03.024","article-title":"Myotonic dystrophy type 1 drug development: A pipeline toward the market","volume":"26","author":"Pascual-Gilabert","year":"2021","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.nmd.2024.08.005_bib0010","doi-asserted-by":"crossref","unstructured":"Gagnon, C., Heatwole, C., H\u00e9bert, L. J., Hogrel, J. Y., Laberge, L., Leone, M., .\u202f.\u202f. Kierkegaard, M. (2018). Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis, 5(4), 523-537. doi:10.3233\/jnd-180329.","DOI":"10.3233\/JND-180329"},{"issue":"7","key":"10.1016\/j.nmd.2024.08.005_bib0011","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.nmd.2015.01.008","article-title":"Report of the second Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-2) international workshop San Sebastian, Spain, October 16, 2013","volume":"25","author":"Gagnon","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.nmd.2024.08.005_bib0012","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.nmd.2013.07.004","article-title":"Report of the first Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-1) international workshop: Clearwater, Florida, November 30, 2011","volume":"23","author":"Gagnon","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2024.08.005_bib0013","doi-asserted-by":"crossref","unstructured":"Wood, L., Bassez, G., van Engelen, B., Lochm\u00fcller, H., & Schoser, B. (2018). 222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016. Neuromuscul Disord, 28(5), 463-469. doi:10.1016\/j.nmd.2018.02.003.","DOI":"10.1016\/j.nmd.2018.02.003"},{"issue":"1","key":"10.1016\/j.nmd.2024.08.005_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nmd.2016.10.003","article-title":"Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study","volume":"27","author":"Gallais","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2024.08.005_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nmd.2014.11.004","article-title":"Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: a five-year prospective cohort study","volume":"25","author":"Hammar\u00e9n","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2024.08.005_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00415-019-09592-7","article-title":"Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1","volume":"267","author":"Laberge","year":"2020","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2024.08.005_bib0017","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1080\/09638288.2020.1837264","article-title":"Predictors of participation restriction over a 9-year period in adults with myotonic dystrophy type 1","volume":"44","author":"Raymond","year":"2022","journal-title":"Disabil Rehabil"},{"issue":"7","key":"10.1016\/j.nmd.2024.08.005_bib0018","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nmd.2017.04.007","article-title":"A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: A similar decline for phenotypes but not for gender","volume":"27","author":"Raymond","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2024.08.005_bib0019","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.apmr.2019.01.022","article-title":"Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1","volume":"100","author":"Raymond","year":"2019","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.nmd.2024.08.005_bib0020","first-page":"77","article-title":"WHO\u2019s ICF and functional status information in health records","volume":"24","author":"Ust\u00fcn","year":"2003","journal-title":"Health Care Financ Rev"},{"key":"10.1016\/j.nmd.2024.08.005_bib0021","doi-asserted-by":"crossref","unstructured":"Compston, A. (2010). Aids to the Investigation of Peripheral Nerve Injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with Aids to the Examination of the Peripheral Nervous System. By Michael O\u2019Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures. Brain, 133(10), 2838-2844. doi:10.1093\/brain\/awq270.","DOI":"10.1093\/brain\/awq270"},{"issue":"2","key":"10.1016\/j.nmd.2024.08.005_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0317167100053397","article-title":"Quantitative motor assessment in myotonic dystrophy","volume":"30","author":"Mathieu","year":"2003","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nmd.2024.08.005_bib0023","unstructured":"Fess, E., & Moran, C. (1981). American Society of Hand Therapists Clinical Assessment Recommendations."},{"issue":"1","key":"10.1016\/j.nmd.2024.08.005_bib0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-510X(83)90135-1","article-title":"Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy","volume":"60","author":"Torres","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2024.08.005_bib0025","doi-asserted-by":"crossref","unstructured":"Merkies, I. S., Schmitz, P. I., Samijn, J. P., Mech\u00e9, F. G., Toyka, K. V., & van Doorn, P. A. (2000). Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve, 23(9), 1393-1401. doi:10.1002\/1097-4598(200009)23:9<1393::aid-mus10>3.0.co;2-o.","DOI":"10.1002\/1097-4598(200009)23:9<1393::AID-MUS10>3.3.CO;2-F"},{"issue":"1","key":"10.1016\/j.nmd.2024.08.005_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1529-8027.2011.00318.x","article-title":"Revised normative values for grip strength with the Jamar dynamometer","volume":"16","author":"Peters","year":"2011","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"10.1016\/j.nmd.2024.08.005_bib0027","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nmd.2022.02.005","article-title":"Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophy","volume":"32","author":"Bulea","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2024.08.005_bib0028","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.nmd.2010.03.010","article-title":"Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ)","volume":"20","author":"Hermans","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2024.08.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139944","article-title":"Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale","volume":"10","author":"Hermans","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.nmd.2024.08.005_bib0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/jnnp.2006.099051","article-title":"Myotonic dystrophy: practical issues relating to assessment of strength","volume":"77","author":"Whittaker","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2024.08.005_bib0031","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2474-11-72","article-title":"The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study","volume":"11","author":"H\u00e9bert","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.nmd.2024.08.005_bib0032","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mus.20822","article-title":"Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)","volume":"36","author":"Moxley","year":"2007","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.nmd.2024.08.005_bib0033","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1474-4422(18)30203-5","article-title":"Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial","volume":"17","author":"Okkersen","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2024.08.005_bib0034","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0895-4356(96)00016-9","article-title":"Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts","volume":"49","author":"Stucki","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624009155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624009155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:22:33Z","timestamp":1778570553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624009155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"alternative-id":["S0960896624009155"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.08.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive four-year disease progression assessment of myotonic dystrophy type 1","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}